InfuSystem Holdings Inc (NYSEAMERICAN:INFU) was the recipient of a large decline in short interest in the month of September. As of September 30th, there was short interest totalling 8,200 shares, a decline of 50.9% from the August 30th total of 16,700 shares. Based on an average trading volume of 27,800 shares, the short-interest ratio is currently 0.3 days. Approximately 0.1% of the company’s shares are short sold.
In other news, major shareholder Awm Investment Company, Inc. bought 16,650 shares of the stock in a transaction on Friday, August 9th. The stock was purchased at an average cost of $4.74 per share, with a total value of $78,921.00. The purchase was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Christopher R. Sansone bought 14,290 shares of the stock in a transaction on Friday, August 30th. The stock was purchased at an average cost of $4.96 per share, with a total value of $70,878.40. The disclosure for this purchase can be found here. Insiders acquired a total of 78,036 shares of company stock valued at $382,592 over the last ninety days.
Several institutional investors and hedge funds have recently made changes to their positions in INFU. White Pine Capital LLC boosted its holdings in shares of InfuSystem by 23.3% in the 2nd quarter. White Pine Capital LLC now owns 494,670 shares of the medical instruments supplier’s stock valued at $2,127,000 after purchasing an additional 93,420 shares during the last quarter. Kennedy Capital Management Inc. acquired a new position in shares of InfuSystem in the 1st quarter valued at $3,374,000. Finally, AWM Investment Company Inc. boosted its holdings in shares of InfuSystem by 9.1% in the 2nd quarter. AWM Investment Company Inc. now owns 1,855,362 shares of the medical instruments supplier’s stock valued at $7,978,000 after purchasing an additional 155,092 shares during the last quarter.
INFU stock traded up $0.04 during midday trading on Friday, hitting $6.45. The stock had a trading volume of 24,500 shares, compared to its average volume of 25,647. InfuSystem has a 12-month low of $2.94 and a 12-month high of $7.17.
InfuSystem (NYSEAMERICAN:INFU) last released its earnings results on Wednesday, August 14th. The medical instruments supplier reported $0.02 EPS for the quarter. The firm had revenue of $19.72 million during the quarter.
InfuSystem Company Profile
InfuSystem Holdings Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.
Featured Story: Compound Interest and Why It Matters When Investing
Receive News & Ratings for InfuSystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InfuSystem and related companies with MarketBeat.com's FREE daily email newsletter.